Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Pharma continues to shine under the pandemic spotlight. The Global RepTrak 100 is the latest to mark the industry's image improvements—noted as the poll’s biggest year-over-year gain among all its industry categories.
Pharma earned a solid No. 8 spot ahead of industries such as retail, transportation and media and entertainment.
Ironically enough, while the bump was attributed to pharma companies’ “key role in getting us through the pandemic,” none of the leading COVID-19 vaccine makers made the top 100. The top-finishing pharma brands were Sanofi (No. 64), Novo Nordisk (No. 71), Eli Lilly (No. 82), Roche (No. 87) and Bristol Myers Squibb (No. 94).